
Composition per film-coated tablet: Glucosamine Sulphate 500 mg (as Glucosamine Sulphate Sodium Chloride) + Chondroitin Sulphate 400 mg (as Chondroitin Sulphate Sodium).
Usage: Joint-health support; evidence for osteoarthritis symptom relief is mixed.
Category: Generic Drugs and Medicine
Therapeutic Category: Joint health
SKU: Glucosamine Sulphate Chondroitin Sulphate Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Glucosamine Sulphate & Chondroitin Sulphate Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)
Glucosamine Sulphate and Chondroitin Sulphate Tablets combine two ingredients commonly marketed for joint health and osteoarthritis symptom management. Research findings are mixed; these products have not been proven to rebuild cartilage or reliably prevent osteoarthritis progression. Healthy Life Pharma Pvt. Ltd. is identified as the manufacturer and Healthy Inc as the exporter.
| Parameter | Specification |
|---|---|
| Product | Glucosamine Sulphate & Chondroitin Sulphate Tablets |
| Composition per tablet | Glucosamine Sulphate 500 mg (added as Glucosamine Sulphate Sodium Chloride); Chondroitin Sulphate 400 mg (added as Chondroitin Sulphate Sodium) |
| Dosage form | Film-coated tablet |
| Therapeutic area | Joint health / osteoarthritis symptom support |
| Other strengths | 750 mg / 600 mg mentioned in supplied description but not composition-confirmed |
| Packaging / shelf life | Confirm from approved product specifications |
Glucosamine salts can be sensitive to moisture, so manufacturing may require controlled humidity, appropriate excipients and protective packaging. Tablet compression, film coating and stability parameters should be established from the actual validated formulation. The stated humidity limits, flavour coating and specific production methods require batch documentation before being claimed.
Relevant checks may include ingredient identity, assay, content uniformity, disintegration, stability and microbiological quality. Source and purity of animal-derived chondroitin should be verified. Testing methods and acceptance criteria depend on the applicable approved specification and market classification.
Glucosamine is involved in the synthesis of glycosaminoglycans; chondroitin is a component of cartilage. However, oral supplementation has inconsistent evidence for meaningful pain relief and has not been established as a treatment that regenerates cartilage. Clinical recommendations vary between jurisdictions. This product should not replace established osteoarthritis care.
The product may be classified differently across countries, including as a supplement or medicine. Registration pathway, permitted claims, certificates, COA, CTD/ACTD availability and export paperwork should be confirmed for each destination and product batch.
Q: Is this a painkiller?
A: It is not an NSAID or fast-acting analgesic. Any symptom benefit is variable and may take time.
Q: Does it rebuild cartilage?
A: There is no reliable clinical proof that this combination rebuilds cartilage or stops osteoarthritis progression.
Q: What about shellfish allergy?
A: Some glucosamine sources are shellfish-derived. Verify the ingredient source and discuss allergies with a healthcare professional.
Q: Is it safe with warfarin?
A: Glucosamine/chondroitin may increase bleeding risk with warfarin; medical review and INR monitoring are important.
The supplied 500 mg/400 mg tablet composition is confirmed. A commonly studied daily amount is 1,500 mg glucosamine plus 1,200 mg chondroitin, but this is not a universal prescribing instruction. Follow the actual product label and healthcare professional advice; do not assume a three-tablet daily regimen is appropriate for everyone.
Possible effects include nausea, heartburn, diarrhoea or constipation. Consult a clinician before use if taking warfarin or other anticoagulants, if pregnant or breastfeeding, if managing diabetes, or if there is a shellfish allergy. Ingredient source and individual circumstances matter. Seek care for signs of bleeding or allergic reaction.
Store in the original container in a dry place, protected from excessive moisture and heat. Follow the labelled temperature conditions and keep out of reach of children.